An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
Julia Ramírez-MoyaChristos MiliotisAllison R BakerRichard I GregoryFrank J SlackPilar SantistebanPublished in: Molecular cancer (2021)
Overall, our data support A-to-I editing as an important pathway in cancer progression and highlight novel mechanisms that might be used therapeutically in thyroid and other cancers.